Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Incyte Corporation

02 3Novartis Pharmaceuticals Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

Ruxolitinib Phosphate

Brand Name : OPZELURA

Dosage Form : CREAM

Dosage Strength : 1.5%/W/W

Packaging :

Approval Date :

Application Number : 2552434

Regulatory Info : Prescription

Registration Country : Canada

blank

02

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

Ruxolitinib Phosphate

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 56/60

Approval Date :

Application Number : 2388006

Regulatory Info : Prescription

Registration Country : Canada

blank

03

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

Ruxolitinib Phosphate

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 56/60

Approval Date :

Application Number : 2388022

Regulatory Info : Prescription

Registration Country : Canada

blank

04

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

Ruxolitinib Phosphate

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 4X14/60

Approval Date :

Application Number : 2434814

Regulatory Info : Prescription

Registration Country : Canada

blank